Trial Outcomes & Findings for Home Sleep and Circadian Phase: Mediators of Diabetes Risk (NCT NCT01786564)

NCT ID: NCT01786564

Last Updated: 2020-11-27

Results Overview

The oral disposition index is based on the glucose and insulin levels during the first 30 minutes of a frequently sampled 5-hour oral glucose tolerance test. It reflects the combination of insulin sensitivity and insulin release in response to the glucose challenge. Higher values suggest a greater response.

Recruitment status

COMPLETED

Target enrollment

120 participants

Primary outcome timeframe

baseline

Results posted on

2020-11-27

Participant Flow

Of 120 participants enrolled in the study, 56 were eligible, continued in the study and provided some data.

Participant milestones

Participant milestones
Measure
Study Sample
This is a cross-sectional study so there is only one group.
Overall Study
STARTED
120
Overall Study
COMPLETED
56
Overall Study
NOT COMPLETED
64

Reasons for withdrawal

Reasons for withdrawal
Measure
Study Sample
This is a cross-sectional study so there is only one group.
Overall Study
Lost to Follow-up
47
Overall Study
Ineligible
17

Baseline Characteristics

Three participants did not have valid actigraphy data so habitual sleep measures could not be calculated. Thus only 53 participants have habitual sleep measures.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Study Sample
n=56 Participants
This is a cross-sectional study so there is only one group.
Age, Categorical
<=18 years
0 Participants
n=56 Participants
Age, Categorical
Between 18 and 65 years
56 Participants
n=56 Participants
Age, Categorical
>=65 years
0 Participants
n=56 Participants
Age, Continuous
30 years
STANDARD_DEVIATION 8.4 • n=56 Participants
Sex: Female, Male
Female
29 Participants
n=56 Participants
Sex: Female, Male
Male
27 Participants
n=56 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=56 Participants
Race (NIH/OMB)
Asian
0 Participants
n=56 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=56 Participants
Race (NIH/OMB)
Black or African American
27 Participants
n=56 Participants
Race (NIH/OMB)
White
29 Participants
n=56 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=56 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=56 Participants
Region of Enrollment
United States
56 participants
n=56 Participants
Body Mass Index (BMI), kg/m2
27.7 kg/m2
STANDARD_DEVIATION 5.3 • n=56 Participants
Habitual Sleep Duration (hours)
402 minutes
STANDARD_DEVIATION 39 • n=53 Participants • Three participants did not have valid actigraphy data so habitual sleep measures could not be calculated. Thus only 53 participants have habitual sleep measures.
Habitual sleep efficiency (% of sleep period sleeping)
90.8 percentage
STANDARD_DEVIATION 3.5 • n=53 Participants • Three participants did not have valid actigraphy data so habitual sleep measures could not be calculated. Thus only 53 participants have habitual sleep measures.
Habitual sleep start time (clock time)
0.27 Hours after midnight
STANDARD_DEVIATION 1.51 • n=53 Participants • Three participants did not have valid actigraphy data so habitual sleep measures could not be calculated. Thus only 53 participants have habitual sleep measures.
Duration of Stage 2 sleep (minutes)
190.6 Minutes
STANDARD_DEVIATION 77.4 • n=51 Participants • Five participants did not have a valid PSG recording. Thus only 51 participants have sleep stage data.
Duration of Stage 3 sleep (minutes)
68.4 Minutes
STANDARD_DEVIATION 30.7 • n=51 Participants • Five participants did not have a valid PSG recording. Thus only 51 participants have sleep stage data.
Duration of Rapid Eye Movement (REM) sleep (minutes)
96.5 Minutes
STANDARD_DEVIATION 49.1 • n=51 Participants • Five participants did not have a valid PSG recording. Thus only 51 participants have sleep stage data.
Fasting glucose levels (mg/dl)
86.8 mg/dl
STANDARD_DEVIATION 6.3 • n=54 Participants • 2 participants were missing valid fasting blood samples so only 54 have a HOMA measure.
Estimated Insulin Resistance (HOMA index method)
1.75 None (Index)
STANDARD_DEVIATION 1.82 • n=54 Participants • 2 participants were missing valid fasting blood samples so only 54 participants have HOMA estimated.
Oral Disposition Index at 30 minutes
11.5 None (Index)
STANDARD_DEVIATION 12.7 • n=53 Participants • 3 participants were missing some blood samples so the oral disposition index could not be calculated in these 3 participants. Thus, only 53 participants have this measure.

PRIMARY outcome

Timeframe: baseline

Population: Three participants did not have adequate glucose and/or insulin values to calculate the disposition index.

The oral disposition index is based on the glucose and insulin levels during the first 30 minutes of a frequently sampled 5-hour oral glucose tolerance test. It reflects the combination of insulin sensitivity and insulin release in response to the glucose challenge. Higher values suggest a greater response.

Outcome measures

Outcome measures
Measure
Study Sample
n=53 Participants
This is a cross-sectional study so there is only one group.
Oral Disposition Index
11.5 None (Index)
Standard Deviation 12.7

Adverse Events

Study Sample

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Kristen Knutson

Northwestern University

Phone: 312-503-1526

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place